Wealthfront Advisers LLC

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1763921 Palo Alto, CA

Position in AQST

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$44,424

-$5,903 QoQ

Shares Held

10,679

-11.9% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#132

of 185 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Wealthfront Advisers LLC holds $10,751,386 across 5 Drug Manufacturers - Specialty & Generic names. AQST ranks #5 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	76,113	$5,469,480
2	VTRS	Viatris Inc	240,584	$3,820,473
3	HIMS	Hims & Hers Health, Inc.	26,931	$933,697
4	UTHR	UNITED THERAPEUTICS Corp	892	$483,312
5	AQST	Aquestive Therapeutics, Inc. This page	10,679	$44,424

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$44,424	10,679	-11.9%	Shares	Sole	2026-08-07
2026-03-31	$50,327	12,127	—	Shares	Sole	2026-05-05
No filing history on record for this holder in this stock.